Observational Study
Copyright ©The Author(s) 2024.
World J Gastrointest Oncol. Jan 15, 2024; 16(1): 118-132
Published online Jan 15, 2024. doi: 10.4251/wjgo.v16.i1.118
Figure 2
Figure 2 The prognostic value of TGF-β1, pSMAD3C, pSMAD3L, and VEGFR-1 in gastric cancer. A-D: The correlation between the expression of (A) pSMAD3C (S423/425), (B) pSMAD3L(S204), (C) TGF-β1, and (D) VEGFR-1 and the overall survval of gastric cancer patients was analyzed using Kaplan-Meier analysis.